Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
BMC Cancer|June 13, 2023
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trialJoris B W Elbers, Pascal A Gunsch, Reno Debets, et al.
Oncoimmunology|April 14, 2017
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacitiesYasmine Van Caeneghem, Stijn De Munter, Paola Tieppo, et al.
Cancers|September 9, 2023
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma PatientsWillem de Koning, Casper W F van Eijck, Fleur van der Sijde, et al.
Frontiers in Immunology|September 25, 2018
Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOSPauline L de Goeje, Yarne Klaver, Margaretha E H Kaijen-Lambers, et al.
International Immunology|March 2, 2006
T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma productionNiels Schaft, Birgit Lankiewicz, Joost Drexhage, et al.
Heliyon|September 12, 2024
T lymphocyte-derived IFN-γ facilitates breast cancer cells to pass the blood-brain barrier: An <i>in vitro</i> study corroborating translational dataRute M S M Pedrosa, Johan M Kros, Benjamin Schrijver, et al.
The Prostate|August 23, 2018
Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) modelPetra W van Duijn, Rute B Marques, Angelique C J Ziel-van der Made, et al.
Molecular Therapy Oncolytics|May 9, 2017
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8<sup>+</sup>T Cell Anti-tumor ActivityAnne Kleijn, Wouter van den Bossche, Erik S Haefner, et al.
Journal of Hematology & Oncology|July 19, 2024
Lipid-based nanosystems: the next generation of cancer immune therapyZiyun Cheng, Seth-Frerich Fobian, Elena Gurrieri, et al.
Nature Communications|September 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancerDora Hammerl, John W M Martens, Mieke Timmermans, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
BMC Cancer|June 13, 2023
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trialJoris B W Elbers, Pascal A Gunsch, Reno Debets, et al.
Oncoimmunology|April 14, 2017
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacitiesYasmine Van Caeneghem, Stijn De Munter, Paola Tieppo, et al.
Cancers|September 9, 2023
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma PatientsWillem de Koning, Casper W F van Eijck, Fleur van der Sijde, et al.
Frontiers in Immunology|September 25, 2018
Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOSPauline L de Goeje, Yarne Klaver, Margaretha E H Kaijen-Lambers, et al.
International Immunology|March 2, 2006
T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma productionNiels Schaft, Birgit Lankiewicz, Joost Drexhage, et al.
Heliyon|September 12, 2024
T lymphocyte-derived IFN-γ facilitates breast cancer cells to pass the blood-brain barrier: An <i>in vitro</i> study corroborating translational dataRute M S M Pedrosa, Johan M Kros, Benjamin Schrijver, et al.
The Prostate|August 23, 2018
Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) modelPetra W van Duijn, Rute B Marques, Angelique C J Ziel-van der Made, et al.
Molecular Therapy Oncolytics|May 9, 2017
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8<sup>+</sup>T Cell Anti-tumor ActivityAnne Kleijn, Wouter van den Bossche, Erik S Haefner, et al.
Journal of Hematology & Oncology|July 19, 2024
Lipid-based nanosystems: the next generation of cancer immune therapyZiyun Cheng, Seth-Frerich Fobian, Elena Gurrieri, et al.
Nature Communications|September 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancerDora Hammerl, John W M Martens, Mieke Timmermans, et al.
Pageof 14